COMMUNIQUÉS West-GlobeNewswire

Inventiva Appoints Andrew Obenshain as Chief Executive Officer
01/10/2025
Daix (France), New York City (New York, United States), October 1, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development [...]
Inventiva annonce la nomination d’Andrew Obenshain au poste de Directeur Général
01/10/2025
Daix (France), New York City (New York, Etats-Unis), le 1 er octobre 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de [...]
Pharming Group announces U.S. FDA acceptance and Priority Review of supplemental New Drug Application for leniolisib in children with APDS aged 4 to 11 years
01/10/2025
If approved, leniolisib will be first and only treatment indicated for children with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare primary immunodeficiency Decision based on positive data [...]

Pages